Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells
- 13 November 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (2), 845-849
- https://doi.org/10.1016/j.bmcl.2007.11.021
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB PathwayClinical Cancer Research, 2007
- HIGHLY ACTIVE ANTICANCER CURCUMIN ANALOGUESPublished by Springer Nature ,2007
- Inhibition of survival signalling by dietary polyphenols and indole-3-carbinolEuropean Journal Of Cancer, 2005
- Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of α,β-unsaturated carbonyl compoundsBiochemical Pharmacology, 2005
- Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powderBiochemical Pharmacology, 2004
- P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cellsCancer Chemotherapy and Pharmacology, 2004
- Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcuminBioorganic & Medicinal Chemistry Letters, 2002
- Dysregulation of Apoptosis in CancerJournal of Clinical Oncology, 1999
- Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcuminBreast Cancer Research and Treatment, 1999
- Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure–activity relationshipsCancer Letters, 1998